Employees at Achilles Therapeutics are bracing themselves ... therapy programme and shutting down the phase 1/2a CHIRON and THETIS clinical trials. In a statement, chief executive Iraj Ali said ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果一些您可能无法访问的结果已被隐去。
显示无法访问的结果